Dermapharm Holding SE (DMP) — Free Cash Flow Generation Index
Dermapharm Holding SE (DMP) has a Free Cash Flow Generation Index of 0.70x as of March 2026. Free cash flow of €27.65 Million represents 1% of operating cash flow (€39.49 Million). Explore DMP capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dermapharm Holding SE Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Dermapharm Holding SE across 12 annual periods. For the full cash flow conversion analysis, see DMP cash generation efficiency.
Annual Free Cash Flow Generation for Dermapharm Holding SE (2014–2025)
Year-by-year Free Cash Flow Generation Index for Dermapharm Holding SE. Check DMP capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.77x | €139.39 Million | €181.51 Million | €42.12 Million | ▼ -5.2% |
| 2024 | 0.81x | €163.14 Million | €201.38 Million | €38.24 Million | ▼ -0.1% |
| 2023 | 0.81x | €177.88 Million | €219.42 Million | €41.54 Million | ▼ -6.3% |
| 2022 | 0.86x | €249.52 Million | €288.53 Million | €39.01 Million | ▲ +14.5% |
| 2021 | 0.76x | €189.16 Million | €250.37 Million | €61.20 Million | ▲ +9.7% |
| 2020 | 0.69x | €90.30 Million | €131.10 Million | €40.80 Million | ▲ +27.9% |
| 2019 | 0.54x | €54.17 Million | €100.61 Million | €46.44 Million | ▼ -35.7% |
| 2018 | 0.84x | €133.16 Million | €159.13 Million | €25.97 Million | ▲ +503.8% |
| 2017 | 0.14x | €12.02 Million | €86.74 Million | €74.72 Million | ▼ -82.0% |
| 2016 | 0.77x | €59.02 Million | €76.78 Million | €17.76 Million | ▲ +22.0% |
| 2015 | 0.63x | €25.44 Million | €40.38 Million | €14.93 Million | ▲ +32.4% |
| 2014 | 0.48x | €25.83 Million | €54.26 Million | €28.42 Million | — |